Literature DB >> 10866215

SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp. I. Fermentation, isolation and properties.

A L Stefanska1, N J Coates, L M Mensah, A J Pope, S J Ready, S R Warr.   

Abstract

A novel, potent and selective inhibitor of bacterial tyrosyl tRNA synthetase, designated SB-219383 has been isolated from Micromonospora sp. NCIMB 40684. The fermentation, isolation and some properties are described, whilst the structure determination is described in the succeeding paper). SB-219383 showed competitive, inhibitory activity against a Staphylococcus tyrosyl tRNA synthetase, with an IC50 of <1 nM, and exhibited weak in vitro activity against some Streptococcus sp.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866215     DOI: 10.7164/antibiotics.53.345

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  10 in total

Review 1.  Structure-based discovery of antibacterial drugs.

Authors:  Katie J Simmons; Ian Chopra; Colin W G Fishwick
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

2.  Leishmania donovani tyrosyl-tRNA synthetase structure in complex with a tyrosyl adenylate analog and comparisons with human and protozoan counterparts.

Authors:  Ximena Barros-Álvarez; Keshia M Kerchner; Cho Yeow Koh; Stewart Turley; Els Pardon; Jan Steyaert; Ranae M Ranade; J Robert Gillespie; Zhongsheng Zhang; Christophe L M J Verlinde; Erkang Fan; Frederick S Buckner; Wim G J Hol
Journal:  Biochimie       Date:  2017-04-18       Impact factor: 4.079

3.  Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors.

Authors:  X Qiu; C A Janson; W W Smith; S M Green; P McDevitt; K Johanson; P Carter; M Hibbs; C Lewis; A Chalker; A Fosberry; J Lalonde; J Berge; P Brown; C S Houge-Frydrych; R L Jarvest
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

4.  The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimer.

Authors:  Eric T Larson; Jessica E Kim; Lisa J Castaneda; Alberto J Napuli; Zhongsheng Zhang; Erkang Fan; Frank H Zucker; Christophe L M J Verlinde; Frederick S Buckner; Wesley C Van Voorhis; Wim G J Hol; Ethan A Merritt
Journal:  J Mol Biol       Date:  2011-03-21       Impact factor: 5.469

Review 5.  The genus Micromonospora as a model microorganism for bioactive natural product discovery.

Authors:  Mohamed S Hifnawy; Mohamed M Fouda; Ahmed M Sayed; Rabab Mohammed; Hossam M Hassan; Sameh F AbouZid; Mostafa E Rateb; Alexander Keller; Martina Adamek; Nadine Ziemert; Usama Ramadan Abdelmohsen
Journal:  RSC Adv       Date:  2020-06-08       Impact factor: 4.036

6.  Characterization of two seryl-tRNA synthetases in albomycin-producing Streptomyces sp. strain ATCC 700974.

Authors:  Yu Zeng; Hervé Roy; Preeti B Patil; Michael Ibba; Shawn Chen
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

7.  Racemic methyl 3,10-dioxa-2-aza-tri-cyclo-[6.2.1.0]undecane-4-carboxyl-ate.

Authors:  Basem A Moosa; Atif Fazal; Shaikh A Ali; Mohammed Fettouhi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-04-29

8.  Two Forms of Tyrosyl-tRNA Synthetase from Pseudomonas aeruginosa: Characterization and Discovery of Inhibitory Compounds.

Authors:  Casey A Hughes; Varesh Gorabi; Yaritza Escamilla; Frank B Dean; James M Bullard
Journal:  SLAS Discov       Date:  2020-06-25       Impact factor: 3.341

Review 9.  Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites.

Authors:  James S Pham; Karen L Dawson; Katherine E Jackson; Erin E Lim; Charisse Flerida A Pasaje; Kelsey E C Turner; Stuart A Ralph
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-11-11       Impact factor: 4.077

10.  Essentiality Assessment of Cysteinyl and Lysyl-tRNA Synthetases of Mycobacterium smegmatis.

Authors:  Sudha Ravishankar; Anisha Ambady; Rayapadi G Swetha; Anand Anbarasu; Sudha Ramaiah; Vasan K Sambandamurthy
Journal:  PLoS One       Date:  2016-01-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.